Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

This publication has 20 references indexed in Scilit:

• Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized
  Tropical Medicine & International Health, 1998
• Reactivation of Chagas' Disease in Patients with AIDS: Report of Three New Cases and Review of the Literature
  Clinical Infectious Diseases, 1997
• In the heart of darkness: sleeping sickness in Zaire
  The Lancet, 1996
• Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities
  Statistics in Medicine, 1995
• Molecular Mechanisms and Therapeutic Approaches to the Treatment of African Trypanosomiasis
  Annual Review of Pharmacology and Toxicology, 1995
• Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994
• Pharmacokinetic Properties of the Trypanocidal Drug Melarsoprol
  Chemotherapy, 1993
• Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis
  The Lancet, 1992
• Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative risk
  Statistics in Medicine, 1990
• Organic arsenic‐induced Guillain‐Barré‐like syndrome due to melarsoprol: A clinical, electrophysiological, and pathological study
  Muscle & Nerve, 1990